Recurrent leg pain and cramping and Labyrinthine fistula

Summary:

Labyrinthine fistula is reported only by a few people with Recurrent leg pain and cramping.

The study analyzes which people have Labyrinthine fistula with Recurrent leg pain and cramping. It is created by eHealthMe based on 1 person who has Labyrinthine fistula and Recurrent leg pain and cramping from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jun, 10, 2023

1 person who has Recurrent Leg Pain And Cramping and Labyrinthine Fistula is studied.

What is Recurrent leg pain and cramping?

Recurrent leg pain and cramping (repeated leg pain and muscle contraction) is found to be associated with 1,321 drugs and 965 conditions by eHealthMe.

What is Labyrinthine fistula?

Labyrinthine fistula (an abnormal opening in the bony capsule of the inner ear) is found to be associated with 66 drugs and 92 conditions by eHealthMe.

Number of Labyrinthine fistula in Recurrent leg pain and cramping reports submitted per year:

Would you have Labyrinthine fistula when you have Recurrent leg pain and cramping?

Gender of people who have Recurrent Leg Pain And Cramping and experienced Labyrinthine Fistula *:

female: 0.0 %
male: 100 %

Age of people who have Recurrent Leg Pain And Cramping and experienced Labyrinthine Fistula *:

Common co-existing conditions for these people *:

Type 2 Diabetes: 1 person, 100.00%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 100.00%
Pancreatic Insufficiency: 1 person, 100.00%
Gastric Ulcer (stomach ulcer): 1 person, 100.00%

Common symptoms for these people *:

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Labyrinthine fistula?

Check whether Labyrinthine fistula is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Recurrent leg pain and cramping (4,066 reports)
Labyrinthine fistula (22 reports)

COVID vaccines that are related to Labyrinthine fistula:

All the drugs that are associated with Labyrinthine fistula:

Labyrinthine fistula (66 drugs)

All the conditions that are associated with Labyrinthine fistula:

Labyrinthine fistula (92 conditions)

How the study uses the data?

The study is based on Labyrinthine fistula and Recurrent leg pain and cramping, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.